7 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp05438 | Peptide-20 | CSSRTMHHC | Synthetic Peptide | Inducing apoptosis | MTT/MTS assay | HL-60 | Leukemia cancer | At 100 µM 90% viablity |
| dbacp05439 | Peptide-20 | CSSRTMHHC | Synthetic Peptide | Inducing apoptosis | MTT/MTS assay | MDA-MB-231 | Breast cancer | At 100 µM 55% viablity |
| dbacp05440 | Peptide-20 | CSSRTMHHC | Synthetic Peptide | Inducing apoptosis | MTT/MTS assay | HeLa | Cervical cancer | At 100 µM 50% viablity |
| dbacp05441 | Peptide-20 | CSSRTMHHC | Synthetic Peptide | Inducing apoptosis | MTT/MTS assay | B16F10-Nex 2 | Skin cancer | At 100 µM 50% viablity |
| dbacp05442 | Peptide-20 | CSSRTMHHC | Synthetic Peptide | Inducing apoptosis | MTT/MTS assay | A-2058 | Skin cancer | At100 µM 30% viablity |
| dbacp05443 | Peptide-20 | CSSRTMHHC | Synthetic Peptide | Inducing apoptosis | MTT/MTS assay | Skmel-25 | Skin cancer | At 100 µM 55 - 60% viablity |
| dbacp05444 | Peptide-20 | CSSRTMHHC | Synthetic Peptide | Inducing apoptosis | MTT/MTS assay | Skmel-28 | Skin cancer | At 100 µM 35 - 40% viablity |